CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BMY — Bristol Myers Squibb Co
CIK 884546
SAN FRANCISCO, CA
Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,706,647,372
-$140,482,452 QoQ
Shares Held
61,115,373
-14.3% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9974163620011.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0025836379989041384.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. BMY ranks #5 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,706,647,372 | 61,115,373 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,847,129,824 | 71,322,392 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,294,118,567 | 73,040,323 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,277,456,057 | 70,802,680 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,696,415,135 | 60,606,905 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,410,594,866 | 60,300,475 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,157,713,051 | 61,030,403 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,452,831,321 | 59,061,674 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,913,016,836 | 53,715,966 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $582,969,699 | 11,361,717 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $651,609,392 | 11,226,902 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $717,888,247 | 11,225,774 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $786,908,728 | 11,353,466 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $806,350,773 | 11,207,099 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $791,673,311 | 11,136,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $833,505,442 | 10,824,746 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $803,729,693 | 11,005,473 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $673,908,291 | 10,808,473 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $631,904,003 | 10,679,466 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $691,800,890 | 10,353,201 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $640,675,941 | 10,148,518 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $652,596,663 | 10,520,662 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $633,099,924 | 10,500,911 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $656,371,993 | 11,162,789 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,093,717,961 | 19,621,779 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||